New study in JNCCN highlights rapid adoption

JNCCN study sheds light on a rapid shift in practice evolution by oncologists treating people with colon cancer adjuvantly after primary surgery, following publications from the IDEA collaboration.

Related Keywords

United States ,Americans ,Danielh Ahn ,Katrinas Pedersen , ,Glaxosmithkline ,Panel For Colon Cancer ,Journal Of The National Comprehensive Cancer Network ,Bristolmyers Squibb ,Siteman Cancer Center At Barnes ,Mayo Clinic Comprehensive Cancer Center ,Syncore Biotechnology Co ,Calithera Biosciences Inc ,National Comprehensive Cancer Network ,Ipsen Pharmaceuticals ,Mayo Clinic Or Emory University Heath System ,Washington University School Of Medicine ,Journal Of The National Comprehensive Cancer Networkevaluates ,National Comprehensive Cancer Networkevaluates ,Mayo Clinic Comprehensive Cancer ,Mayo Clinic ,Emory University Heath System ,Colon Cancer ,Associate Professor ,Siteman Cancer Center ,Barnes Jewish Hospital ,Washington University School ,Practice Guidelines ,African Americans ,Prescribing Patterns ,National Comprehensive Cancer ,Englj Med ,Taiho Oncology ,Calithera Biosciences ,Syncore Biotechnology ,Suzhou Transcenta ,